Abstract
The cardiac troponin complex (cTn) is an important regulatory protein in heart contraction. Upon binding of Ca2+, cTn undergoes a conformational shift that allows the troponin I switch peptide (cTnISP) to be released from the actin filament and bind to the troponin C hydrophobic patch (cTnCHP). Mutations and modifications to this complex can change its sensitivity to Ca2+ and alter the energetics of the transition from the Ca2+-unbound, cTnISP-unbound form to the Ca2+-bound, cTnISP-bound form. We utilized targeted MD (TMD) to obtain a trajectory of this transition pathway, followed by umbrella sampling to estimate the free energy associated with the cTnISP-cTnCHP binding and the cTnCHP opening events for wild-type (WT) cTn. We were able to reproduce experimental values for the cTnISP-cTnCHP binding event and obtain cTnCHP opening free energies in agreement with previous computational measurements of smaller cTnC systems. This excellent agreement for WT cTn demonstrated the strength of computational methods in studying the dynamics and energetics of cTn complex. We then introduced mutations to the cTn complex that cause cardiomyopathy or alter its Ca2+-sensitivity and observed a general decrease in the free energy of opening the cTnCHP. For these same mutations, we observed no general trend in the effect on the cTnISP-cTnCHP binding event. Our method sets the stage for future computational studies on this system that predict the consequences of yet uncharacterized mutations on cTn dynamics and energetics.
Introduction
Contraction of the thin filament in heart muscle is regulated by Ca2+ binding to the cardiac isoform of the troponin (cTn) complex.1 Upon binding of Ca2+ to cTn, a conformational shift occurs that releases cTn from actin, exposing myosin binding sites that allow muscle contraction to occur. The exact mechanism of the cTn conformational transition and how mutations cTn effect his process is still not fully understood.
The cTn complex is comprised of 3 subunits: the Ca2+-binding subunit (cTnC), the inhibitory subunit (cTnI), and the tropomyosin binding structural subunit (cTnT) (Figure 1). cTnC can be divided in two regions: N-terminal cTnC (NcTnC, residues 1–89) contains Ca2+-binding sites I and II, and C-terminal cTnC (CcTnC, residues 90–161) contains Ca2+-binding sites III and IV. Under normal physiological conditions, sites III and IV are always occupied, and site I is never occupied by Ca2+. Thus, site II of NcTnC is predominately responsible for sensing Ca2+ for muscle contraction. When Ca2+ binds to site II, it induces a conformational and dynamical shift that exposes a hydrophobic patch (cTnCHP) in NcTnC that is able to bind the cTnI switch peptide (cTnISP, residues 149–164). The cTnISP (along with the cTnI inhibitory peptide) interacts with actin in the Ca2+-unbound state, and its dissociation from actin and subsequent binding to the cTnCHP in the cTn Ca2+-bound state allows for the thin filament interaction with myosin necessary for muscle contraction.
Figure 1. Cartoon representation of the cardiac troponin complex (cTn).

A) TMD starting model representing Ca2+-unbound, cTnISP-unbound cardiac troponin (PDB: 6KN7, chains a, b, and c). B) TMD final model representing Ca2+-bound, cTnISP-bound cardiac troponin (PDB: 6KN8, chains a, b, and c). cTnT is depicted in purple, cTnI is cyan, and cTnC is red. Helices A and B (residues 14–48, cTnCHP) of cTnC are shown in orange and labeled HA and HB, respectively. The cTnISP (cTnI residues 149–164) are shown in green. Ca2+ ions added by Autodock Vina are yellow.
Mutations throughout the cTn complex subunits have been shown to cause cardiomyopathy, a disease that can lead to heart failure or sudden cardiac death.2 3 types of cardiomyopathy caused by these mutations include: Hypertrophic (HCM), Restrictive (RCM), and Dilated (DCM). HCM causes thickening of the interventricular septum, leading to decreased ventricular filling and impaired diastolic function of the heart. RCM is a rarer disease but causes similar problems with decreased ventricular filling without thickening of the heart muscle. Both HCM and RCM mutations have been shown to increase Ca2+-sensitivity in cTnC. DCM has been shown to decrease cTnC Ca2+-sensitivity, with physiological affects including an increase in the size of the left ventricle, or both ventricles, and impaired systolic function.3
Structurally, cTn has been well characterized. A partial crystal structure of the Ca2+-bound cTn complex, published by Takeda et al.4 in 2003, constituted a major advancement of our structural understanding of the complex. More recently, a cryo-EM structure of the entire cTn complex in the context of the thin filament was published by Yamada et al.5 This study was able to elucidate structures of the cTn complex, anchored onto the thin filament, in the Ca2+-bound and Ca2+-unbound states. Although this breakthrough was able to provide snapshots of the cTn complex and thin filament in both states, it was unable to provide information on the conformational transition and thermodynamic pathway between the two. A quantitative assessment of these processes is desirable for our understanding of heart muscle biology and disease, drug discovery and protein design.
Computational methods can facilitate the study of these processes.6 Previous efforts have been able to utilize molecular dynamics (MD) and free energy methods to study Ca2+-binding to cTnC site II.7, 8, 9,10 ,11 MD methods have also been able to investigate disruptions in dynamics upon the introduction of mutations that alter site II’s Ca2+-sensitivity or mutations that have been linked with disease.12, 13, 14 Enhanced sampling methods, umbrella sampling, and long timescale simulations have been utilized to study the energetic pathway for the transition between Ca2+-unbound and Ca2+-bound forms.15, 16, 17, 18 Simulations have also incorporated cTnI into the system to elucidate how other subunits in the cTn complex can affect the dynamics of cTnC.19, 20, 21, 22, 23, 24 Computer aided drug discovery has also proven effective in helping identify potential therapeutics for heart disease by targeting the cTn complex.25, 26, 27, 28, 29
How mutations located in regions not involved in either the coordination of Ca2+ to site II or the cTnISP-cTnCHP binding event can alter the overall dynamics of muscle contraction, remains underexplored. One hypothesis on how some of these mutations, particularly those in the cTnI inhibitory peptide (cTnIIP), may affect troponin function was that they alter the availability, or effective concentration, of the cTnISP to the cTnCHP. Our lab previously explored this hypothesis by determining the volume sampled by the cTnISP during MD simulations. We saw no significant difference in cTnISP effective concentration between WT and mutations in the cTnI inhibitory peptide (residues 137–148),19 leading us to search for other computational methods to explore the effects of mutations on cTnC dynamics.
Another interesting interaction that has been, at least computationally, underexplored is the binding of the cTnISP to the cTnCHP region. Experimentally, this has been studied before by Li et al. in an NMR kinetic study of cTnI147–163 titrated into a Ca2+-bound NcTnC. The authors estimated a binding KD of 154μM.30 Another experiment by Tikunova et al. estimated the binding affinity to be 200nM using IAANS fluoresence,31 measuring an almost three orders of magnitude difference as compared to the first study. The difference is likely explained by the different sequences of cTnI used, where the NMR experiment used residues cTnI147–163, and the fluorescence experiment used cTnI128–180. Because residues C-terminal of the cTnISP are largely structural,6 the additional 17 residues located on the C-terminal end of the cTnISP may significantly increase the binding affinity of cTnISP to the cTnCHP. In order for the cTnISP to bind to the cTnCHP, cTnC first needs to undergo an opening event. Although this event is difficult to measure experimentally,32 it has been studied computationally before by Bowman et al. using a model of just the N-terminal region of cTnC.16
We therefore set out to estimate the free energy associated with the cTnISP-cTnCHP binding and the opening of the cTnCHP using a combination of MD-based simulations and free energy methods. To obtain a trajectory of conformations between the Ca2+-unbound, cTnISP-unbound structure and the Ca2+-bound, cTnISP-bound structure, we employed targeted molecular dynamics (TMD). This specific type of MD simulation can steer a starting model towards a target model by applying an additional potential energy function.33 The implementation of this MD method has been shown recently to help elucidate transition pathways of other proteins.34, 35 Using the conformations along this transition, we performed umbrella sampling to determine the free energy associated with two separate events: opening of the cTnCHP and cTnISP binding to cTnCHP. We also applied this same method to mutations known to be linked with HCM or RCM, one mutation that was experimentally designed to increase Ca2+-sensitivity of cTnC, and the phosphorylation of cTnI Thr143. Given that Ca2+-binding causes opening of the cTnCHP, we hypothesized that mutations linked with HCM or RCM and/or known to experimentally increase Ca2+-sensitivity would lower the free energy associated with the cTnCHP opening event. For the cTnISP-cTnCHP interaction, we hypothesized that these same mutations may cause the free energy of cTnISP-cTnCHP binding to become less favorable due to the mutations potentially disturbing important residue-residue contacts necessary for binding.
We were able to make two important observations from these simulations. First, our TMD method followed by umbrella sampling was able to calculate values for both the cTnCHP opening and cTnISP binding free energies in agreement with previous experimental and computational studies. This agreement allowed us to conclude that our method is a reliable way to study the free energy profile of the transition between Ca2+-unbound and bound conformations of cTn. Second, we saw a general slight decrease in free energy of the cTnCHP opening upon introduction of mutations linked with HCM and RCM, as well as the Ca2+-sensitizing mutation L48Q. However, we did not observe a general weakening or strengthening of the cTnISP-cTnCHP binding upon introduction of these same mutations.
Methods
Model Preparation for TMD
To run TMD, a start and end point for the cTn complex simulations needed to be obtained. For the starting model, chains a, b, and c from PDB entry 6KN75 were extracted (Figure 1A). This model provides atom positions for all three subunits of cTn in the Ca2+-unbound, cTnISP-unbound form in the context of the thin filament. For the end point of the TMD simulation, chains a, b, and c from PDB entry 6KN85 were extracted (Figure 1B). This model provides atom positions for all three subunits of cTn in the Ca2+-bound, cTnISP-bound form in the context of the thin filament. Since TMD requires identical atoms for the start and end models, the following residues for both extracted models were used in the simulations: cTnC residues 2–161, cTnI residues 41–166, and cTnT residues 199–272. Neither of these two PDBs provided information on the position of Ca2+ ions, so Ca2+ was added to sites II, III, and IV of the cTnC in both models using AutoDock Vina.36 Although the 6KN7 model represents a Ca2+-unbound, cTnISP-unbound form of the cTn complex, Ca2+ binding initiates the conformational change to the cTnISP-bound form of the cTn complex, making the addition of Ca2+ to site II of the start model necessary to simulate the conformational change appropriately.
TMD Optimization and Simulations
For the TMD simulations, the structures were solvated with explicit TIP3W water molecules and NaCl counterions were added to neutralize the entire system and establish a final salt concentration of 150mM. The system was minimized over two sequential 10,000 minimization steps to optimize the positions of the solvent molecules around the protein and to subsequently relax the positions of residue side chain atoms. The system was then slowly heated up to 310K over an initial equilibration of 190,000 steps, followed by a final equilibration of 10,000 steps to bring the system into the final production run conditions. Pressure was controlled at atmospheric conditions during equilibration simulations using Langevin piston pressure control. All preparation steps and TMD simulations were conducted using NAMD 2.1337 and a 2 femtosecond timestep. Parameters for all atoms within the simulation were determined from the Charmm36 force field.38 Although previous studies have detailed difficulties of modeling Ca2+ ion interactions and Ca2+-binding free energies in molecular dynamics simulations involving biomolecules, the Charmm36 force field has been shown as a reliable force field option for producing experimental-like configurations of proteins in simulations where Ca2+ is bound to an EF-hand protein (i.e., Troponin).39 The TMD simulations were conducted using an NPT ensemble at 310K with Langevin temperature and pressure dampening. All bonds with hydrogens were constrained using the ShakeH algorithm which allowed for a 2 femtosecond timestep, with structures being saved every 2 picoseconds.
Three independent TMD simulations were performed for 60ns using a force constant of k = 200kcal/mol/Å2. Technical details of TMD simulations, the process for determining optimal parameters for the cTn system, as well as post-simulation processing and analysis of the trajectories are described in Supplemental Information. For each frame in these trajectories, two values were determined: interhelical distance between cTnC helices A and B, and the distance between the cTnISP and the cTnC hydrophobic patch. Interhelical distance was used as a proxy for interhelical angle to evaluate the degree of openness of the hydrophobic patch by measuring the distance between residues 14 and 48 of cTnC. The position of residues 14 and 48 in each frame, respectively, was determined by averaging the position of the residues’ N, C, and CA atoms. The distance between the cTnISP (residues 149–164) and the cTnCHP (residues 20, 23, 24, 26, 27, 36, 41, 44, 48, 57, 60, 77, 80, 81) was determined by calculating the average position of the CA atoms in the collective group of residues for each region and measuring the distance between the two centers of mass. The trial that exhibited the most sampling close to the line of regression was selected as the representative trajectory from which frames were extracted to run umbrella sampling.
Umbrella Sampling
Specific frames from the representative TMD trajectories were selected as windows for umbrella sampling (US) simulations (Table S1). The timestep for these simulations was set to 1fs. For each US window, two independent sets of simulations were performed: one set of simulations with the cTnCHP interhelical distance as a collective variable, and another independent set of simulations with the cTnISP-cTnCHP distance as a collective variable. The variables were defined as shown in Table S1 and a harmonic force constant of 5 kcal/mol was applied. Interhelical distance was restrained by evaluating the distance between the average position of atoms N, C, and CA in residues 14 and 48 of cTnC. cTnISP-cTnCHP distance was restrained by evaluating the average position of the CA atoms in the collective group of residues for each region (see TMD section above). Each of the 27 windows was then run for 8 ns in 3 independent simulations for each of the collective variables, at 310K under an NPT ensemble, similar to the TMD simulations.
Simulations that used cTn structures with cardiomyopathic mutations, phosphorylation, or Ca2+-sensitizing mutations were created by modifying the windows described above. We selected all cTn mutations in the cTnIIP, cTnISP, and NcTnC regions that have been previously linked with cardiomyopathy.2 For many of those mutations, unfortunately, there was no experimental data on available the free energy of opening the cTnCHP or the cTnIIP binding affinity. The designed L48Q mutation in the NcTnC region was included due to extensive experimental research revealing that the mutation has a Ca2+-sensitizing effect.40, 41 The posttranslational modification of T143 has been shown to physiologically occur and has been suggested to cause a Ca2+-sensitizing effect.42 For cardiomyopathic or Ca2+-sensitizing mutations, the mutations were introduced to each window using the Mutagenesis Wizard function available in PyMOL.43 Mutations introduced to cTnC include: A8V, L29Q, A31S, L48Q, and C84Y. Mutations introduced to cTnI include: R141Q, L144P, L144Q, R145G, R145Q, R145W, A157V, R162P, R162Q, and R162W. The cTnI Thr143 phosphorylated (T143p) windows were created using the PyTMs plug-in available in PyMOL.44 Each of the modified windows were also run for 8 ns in 3 independent simulations, at 310K under an NPT ensemble.
WHAM Free Energy Estimation
For each frame in each US trajectory, the values of the applied collective variable were evaluated. The Weighted Histogram Analysis Method (WHAM)45 was used to create a free energy profile based on the individual collective variable evaluated. This allowed us to estimate free energy profiles of the cTnCHP opening transition coordinate and cTnISP association coordinate, respectively, without bias of the other collective variable restraining the system during simulation.
The final reported values for the free energy attributed to each collective variable were determined by averaging the data from the three independent simulations for each system, with errors being reported as the sample standard deviation between the three trials. The minimum and maximum values provided to WHAM for the interhelical distance collective variable were 14.5Å and 28.5Å, respectively. The minimum and maximum values provided to WHAM for the cTnISP-cTnCHP distance collective variable were 9.6Å and 16.2Å, respectively. The histogram analysis for both profiles was divided into 27 bins, one for each of the windows simulated, with the center of the bin being defined as the energy minimum for the window. A tolerance of 0.00001 was applied, and a force constant of 10 kcal/mol was used after properly adjusting the 5 kcal/mol spring constant applied in the charmm36 force field. Adjustment of the spring constant for implementing WHAM was necessary because the charmm36 force field does not include a ½ when specifying spring constants for the restraint terms, yet the code for WHAM does. This force constant adjustment is described in “An implementation of WHAM: the Weighted Histogram Analysis Method” by Alan Grossfield.45
Results
TMD Simulations Generate a Transition Pathway for Umbrella Sampling
Targeted MD simulations were used to obtain a trajectory of the transition from a Ca2+-unbound, cTnISP-unbound cTn complex to a Ca2+-bound, cTnISP-bound cTn complex. We optimized two variables in the potential energy function for the TMD term: the force constant, k (kcal/mol/Å2), and the length of the simulation, t. TMD simulations were run for five separate force constants, at increasing simulation lengths. For each simulation, the interhelical angle between cTnC helices A and B for all frames captured from the trajectories was determined. TMD trajectories run for t = 20ns and t = 40ns exhibited abnormally high interhelical angles for the lowest three force constants (k = 50kcal/mol/Å2, k = 100kcal/mol/Å2, k = 200kcal/mol/Å2), while higher force constants (k = 500kcal/mol/Å2, k = 1000kcal/mol/Å2) led to a rapid cTnCHP opening (Figure S1). Additionally, visual inspection for all these simulations revealed denaturation of the cTnISP into a disordered region before interaction with the cTnCHP. For the t = 60ns simulations, the trajectories with k = 50kcal/mol/Å2 and k = 100kcal/mol/Å2 force constants again experienced unnaturally high interhelical angles. The k = 200kcal/mol/Å2 and k = 500kcal/mol/Å2 trajectories exhibited sufficient sampling of both the closed and open states of the cTnCHP while also sampling a smooth transition between the two (Figure 2). Visual inspection of the cTnISP region revealed that cTnISP maintained its helical nature for both force constants throughout the 60ns simulation. We therefore chose to move forward with the parameters t = 60 ns and k = 200 kcal/mol/Å2 to avoid denaturation of parts of the Tn complex. Simulations ran for t = 80 ns and t = 100 ns across all force constants also sampled the anticipated ranges of interhelical angles and exhibited gradual cTnCHP opening events, but we decided to use the shorter t = 60ns simulations for production runs.
Figure 2. Interhelical angle throughout the 60ns TMD simulations.

Time of the simulation vs. interhelical angle of NcTnC helices A and B. The grey ‘cutoff’ line at the 105° mark was added to differentiate between open and closed conformations. Force constants are colored: Red (k = 50kcal/mol/Å2), Yellow (k = 100kcal/mol/Å2), Green (k = 200kcal/mol/Å2), Blue (k = 500kcal/mol/Å2), and Purple (k = 1000kcal/mol/Å2).
Three independent trials of TMD of the WT cTn complex were run using these parameters (k=200 kcal/mol/Å2 and simulation length of 60ns) and the sampling along the cTnCHP patch opening coordinate was investigated. The correlation between interhelical angle and interhelical distance for helices A/B can be seen in Figure S2. Furthermore, the data for each frame in the trajectories was analyzed with respect to the interhelical and cTnISP-cTnCHP distances, with a line of regression being created along the patch opening event (Figure 3A). To obtain full coverage of the transition coordinate between the closed and open hydrophobic patch, target values for the interhelical distance were set every 0.5Å between 15.0Å and 28.0Å, creating 27 target interhelical distances. This corresponded to interhelical angles ranging from approximately 95° to 130°. Each of these values was paired according to the regression with a target cTnISP-cTnCHP distance to obtain full coverage of the transition coordinate between an unbound cTnISP to a bound cTnISP. This resulted in 27 windows with pairs of target values, ranging from window 1 with a closed cTnCHP and unbound cTnISP (interhelical distance = 15.0Å, cTnISP-cTnCHP distance = 15.7Å) to window 27 with an open cTnCHP bound to the cTnISP (28.0Å, 10.3Å) (Figure 3B). Figures 3C, 3D, and 3E show the starting conformation of the cTn complex for windows 1, 14, and 27, respectively. Window 1 shows the cTnISP near a closed cTnCHP, window 9 contains the cTnISP in a primed position to bind to the cTnCHP (while the patch is only in a semi-open conformation), and window 27 corresponds to the cTnISP completely bound to an open cTnCHP.
Figure 3. TMD trajectory analysis and window extraction.

A) Each point represents a frame from the TMD trajectory. Line of regression was created using all data points where the interhelical distance ≥ 19.0Å. B) Each point represents one of the 27 windows extracted for input of umbrella sampling. The same line of regression from (A) is shown in orange. Simulation windows shown in (C), (D), and (E) are labeled with arrows. C) Window 1 with an interhelical distance of 15.0Å and a cTnISP-cTnCHP distance of 15.8Å. This window has the cTnISP near a closed cTnCHP and represents the start point of the transition coordinate. D) Window 9 with an interhelical distance of 19.0Å and a cTnISP-cTnCHP distance of 14.1Å. This window has the cTnISP in a primed position to bind to the cTnCHP, however the patch is only in a semi-open conformation. E) Window 27 with an interhelical distance of 28.0Å and a cTnISP-cTnCHP distance of 10.3Å. This window has the cTnISP completely bound to an open cTnCHP and represents the end point of the transition coordinate. All regions of the cTn complex are colored identical to Figure 1. cTnC helices A and B (orange) labeled as HA and HB, respectively.
WT Free Energies of Patch Opening and Switch Peptide Binding Agree with Previous Experiments
For the wild-type system, we simulated the 27 extracted windows in triplicate for each collective variable using umbrella sampling and evaluated the results with WHAM. We created a free energy profile considering each collective variable independently (Figure 4). Analysis of the umbrella sampling simulations revealed that the evenly spaced windows exhibited sufficient overlap and that we were able to sample the entire reaction coordinate (Figure S3). Evaluating the convergence of the free energy calculated by WHAM as a function of simulation time revealed that 8 ns was sufficient for sampling the windows of both collective variables (Figure S4). The free energy estimated for the cTnISP binding event only fluctuated by about 0.1 kcal/mol after 5 ns (Figure S4A) and the cTnCHP opening free energy only changed by 0.3 kcal/mol after 5 ns (Figure S4B). The estimated free energy of the cTnISP-cTnCHP binding event was then determined to be −5.4 ± 0.5 kcal/mol. Figure 4A shows the calculated free energy per window as a function of the distance between the cTnISP and cTnCHP. The free energy was measured from the peak of the free energy curve in window 7 (the unbound state; at a cTnISP-cTnCHP distance of about 14.5Å) to the free energy estimation in the last window (the bound state; at a cTnISP-cTnCHP distance of about 10.3Å; window 27). This was done because the cTnISP was not in proximity to the cTnCHP binding site until window 7, when the patch opening reached a semi-open conformation suitable for cTnISP-cTnCHP binding to commence.
Figure 4. WHAM calculated free energy of wild-type transition coordinates.

A) The free energy across the cTnISP-cTnCHP binding coordinate for the wild-type cTn model. Binding occurs right (window 7) to left (window 27) as the distance between the two entities decreases. B) The free energy across the cTnCHP opening coordinate. The cTnCHP opens from left (window 1) to right (window 27).
An NMR kinetic study of cTnI147–163 titrated to a Ca2+-bound NcTnC estimated a binding KD of 154 ± 10 μM.30 This experimental study is the most comparable to our simulation data because a highly similar region for the cTnISP was used. At T = 303.15 Kelvin (30° C), this data corresponds to an experimentally determined free energy of −5.3 ± 0.1 kcal/mol, a value in perfect agreement with our computational value of −5.4 ± 0.5 kcal/mol. Other experimental studies explored the binding of longer cTnI segments to cTnC. However, since residues located C-terminally of the cTnISP were not resolved in the 6KN8 PDB structure, we were unable to test the effect of these residues on the switch peptide binding affinity. Given this small deviation, we hypothesized that our method of using TMD to produce windows representative of a transition coordinate, in combination with umbrella sampling to measure the free energy along that coordinate, can reliably reproduce experimentally determined free energy values of events associated with the cTn conformational transition. Applying the same strategy to the cTnCHP opening transition coordinate, we estimated the free energy of the opening event to be 12.0 ± 1.3 kcal/mol. The WHAM determined free energy as a function of the opening coordinate can be seen in Figure 4B. Although the free energy of this event has not been studied experimentally, the result agrees with previous computational simulations that measured the free energy of cTnCHP opening in NcTnC to be 13.8 ± 2.2 kcal/mol using a combination of steered MD and umbrella sampling.16
To test the effect of the cTnISP getting incrementally closer to a closed hydrophobic patch, we extracted 11 windows from our TMD simulations (each at a cTnCHP interhelical distance of 15Å), with a decreasing cTnISP-cTnCHP distance between 25Å and 20Å (step size 0.5Å). Between these windows, we observed only a small change in free energy (~1.8 kcal/mol) as the cTnISP shifted its position closer to the cTnCHP (Figure S5). We would not expect this small difference to significantly affect the reported results.
HCM and RCM Mutations Generally Decreased cTnCHP Opening Free Energy
After developing a reliable method to measure the free energy of the cTnCHP opening and cTnISP-cTnCHP binding events, we subsequently introduced mutations and posttranslational modifications in cTn to determine how these changes affect the free energies of patch opening and switch peptide binding. We tested 12 mutations that have been linked with HCM, two mutations linked with RCM, one designed mutation that increases Ca2+-sensitivity without causing disease, and phosphorylation of cTnI Thr143. All modifications tested were located in the NcTnC region, or between residues 141–162 of cTnI. Data for the estimated free energy of patch opening and switch peptide binding for all 16 modified systems can be seen in Table 1. Two of the mutations (cTnC L48Q and C84Y) exhibited a significant decrease in the free energy of cTnCHP opening (Figure 5A), while the other 13 mutations caused no significant change in the free energy.
Table 1. Free energy of cTnCHP opening and cTnISP binding events for all models.
All data shown in units of kcal/mol.
| Model | Disease | ΔG cTnCHP Opening | ΔG cTnISP Binding |
|---|---|---|---|
| Wild-Type | --- | 12.0 ± 1.3 | −5.4 ± 0.5 |
| cTnC A8V | HCM | 11.6 ± 1.7 | −3.9 ± 1.3 |
| cTnC L29Q | HCM | 13.1 ± 1.8 | −7.2 ± 1.2 |
| cTnC A3 IS | HCM | 11.4 ± 1.0 | −4.3 ± 1.0 |
| cTnC L48Q | --- | 4.8 ± 1.5 | −8.0 ± 0.2 |
| cTnC C84Y | HCM | 8.4 ± 1.1 | −6.4 ± 0.6 |
| cTnI R141Q | HCM | 13.6 ± 0.7 | −4.3 ± 0.7 |
| cTnI L144P | HCM | 12.3 ± 2.2 | −3.6 ± 1.5 |
| cTnI R145G | HCM | 12.5 ± 1.0 | −5.5 ± 1.0 |
| cTnI R145Q | HCM | 13.5 ± 2.5 | −7.2 ± 0.6 |
| cTnI A157V | HCM | 12.5 ± 1.9 | −5.6 ± 2.2 |
| cTnI R162P | HCM | 12.6 ± 2.5 | −3.5 ± 1.1 |
| cTnI R162Q | HCM | 11.4 ± 1.8 | −4.3 ± 0.9 |
| cTnI R162W | HCM | 11.8 ± 0.9 | −4.4 ± 1.3 |
| cTnI L144Q | RCM | 11.7 ± 2.5 | −4.7 ± 0.5 |
| cTnI R145W | RCM | 10.4 ± 1.8 | −5.6 ± 1.0 |
| cTnI T143p | --- | 15.6 ± 0.9 | −4.6 ± 1.5 |
Figure 5. Free energy of cTnCHP opening and cTnISP binding events for all simulated systems that caused a significant impact.

A) WHAM calculated ΔG for the cTnCHP opening event for cTn systems ordered based on average ΔG. B) WHAM calculated ΔG for the cTnISP binding event for cTn systems ordered based on average ΔG. Standard deviations for each system are shown as black bars.
Two mutations had a drastic effect on the cTnCHP opening: L48Q (4.8 kcal/mol), C84Y (8.4 kcal/mol). Interestingly, the mutation that caused the biggest change in free energy of this opening event was L48Q, a designed cTnC Ca2+-sensitizing mutation which has not been linked with disease.40, 41 This mutation also caused the most favorable cTnISP-cTnCHP interaction (−8.0 kcal/mol) amongst all mutations studied (see next section). The only cardiomyopathic mutation that we observed having a significant effect on the cTnCHP opening was cTnC C84Y. This mutation has been shown experimentally to increase Ca2+-sensitivity of force generation in skinned cardiac muscle fibers.46
Mutations in the cTnI inhibitory peptide and cTnISP regions did not affect the free energy of cTnCHP opening significantly. Prior experiments have suggested that cTnI mutations that cause a more severe increase in Ca2+-sensitivity lead to RCM, whereas mutations that cause a less severe increase in Ca2+-sensitivity lead to HCM.47 Our data would support this theory since mutations linked with RCM in the cTnI inhibitory peptide and cTnISP regions (L144Q, R145W) generally had a larger effect on the cTnCHP opening free energy when compared to HCM mutations in the same region. Currently, no RCM mutations have been identified in cTnC,2, 48 so we were unable to test this trend amongst the cTnC mutations.
No Observed Trend in cTnISP-cTnCHP Binding Free Energy
We were unable to observe any consistent trend in the free energy of cTnISP-cTnCHP binding. Three mutations (cTnC L29Q, cTnC L48Q, and cTnI R145Q) caused a significantly more favorable interaction, one mutation (cTnI R162P) caused a less favorable interaction, and the other eleven mutations had no measurable effect on cTnISP-cTnCHP binding (Figure 5B and Table 1). The effect of cTn mutations on cTnISP-cTnCHP binding has been scarcely studied before. A study by Tikunova et al. that estimated the binding affinity of cTnI128–180 to cTnC in the presence of Ca2+-sensitizing, non-cardiomyopathic mutations observed a slight increase in KD when compared to the WT.31 We would therefore hypothesize to see a less favorable interaction between the cTnISP and the cTnCHP given mutations linked with HCM or RCM or those that have been experimentally shown to cause a Ca2+-sensitizing effect. Although we did observe slightly less favorable interactions in most of the mutated models, only one model produced a significantly less favorable interaction. For the one Ca2+-sensitizing, non-cardiomyopathic mutation that was studied (L48Q), we observed a significantly more favorable cTnISP-cTnCHP interaction (−8.0 kcal/mol) as compared to WT. Interestingly, the other cTnC mutation that caused a more favorable interaction (L29Q) was also a leucine to glutamine substitution.
Thr143 Phosphorylation May Increase cTnCHP Opening Free Energy
PKA-mediated phosphorylation of cTnI has been shown as a mechanism for increasing the heart rate under stress by allowing the heart muscle to contract at a faster rate as a consequence of a decrease in Ca2+-sensitivity from phosphorylation of cTnI Ser 22/23.49 However, studies of the PKC-mediated phosphorylation of cTnI Thr143 have actually shown the adverse effect, namely that phosphorylation of this site may cause an increase in Ca2+-sensitivity in the myofilament.42 Our phosphorylated model of cTnI Thr143 (cTnI T143p) slightly increased the cTnCHP opening free energy (15.6 kcal/mol) while having no effect on the free energy of cTnISP-cTnCHP binding. Therefore, our simulations suggested that the phosphorylation of cTnI T143 might decrease calcium sensitivity though an increase in the free energy of cTnCHP opening. A possible explanation for this apparent inconsistency with the experimentally observed increase in Ca2+-sensitivity was highlighted in a study by Vymetal et al.50 The authors showed that current force fields were unable to simulate phosphorylated residues in a way that would agree with experimental observations. Therefore, the phosphorylated Thr143 in our cardiac troponin system was most likely behaving uncharacteristically, leading to results that did not corroborate experimental data.
Conclusions
In this study, we modeled the transition of cTn from the Ca2+-unbound to Ca2+-bound states by using targeted molecular dynamics (TMD). Using the trajectory of this transition, we subsequently performed umbrella sampling simulations to determine the free energy associated with two separate events: opening of the cTnCHP and cTnISP binding to cTnCHP. Results obtained for the cTnISP-cTnCHP interaction in the WT model agreed with previous experimental results,30 while our cTnCHP opening free energy estimation agreed with previous computational efforts.16 This excellent agreement for WT cTn demonstrates the important role of advanced computational methods in quantitatively studying cTn dynamics and muscle contraction. The methodology described here, using TMD followed by umbrella sampling, could also be applied to other protein systems given the availability of structures in two different states.
We further applied the methodology to cTn mutations and post-translational modifications. Our results showed that mutations linked with HCM or RCM caused a Ca2+-sensitizing effect, generally lowering the free energy associated with the cTnCHP opening. We observed that most of the studied mutations caused a less favorable free energy associated with cTnISP-cTnCHP binding, although this trend did not hold for all HCM and RCM mutations, with three mutations leading to significantly more favorable binding free energies for this event. Our method could impact the future of computational studies on this system by predicting the consequences of unknown mutations on cTn energetics. Additionally, this method could prove helpful in rational protein design. Overall, we showed that our protocol of utilizing umbrella sampling to measure the free energy of transitions sampled by TMD is a reliable method for studying the energetics of the cTn complex.
Supplementary Material
Acknowledgements
The authors would like to thank Marcos Sotomayor for sharing his expertise with respect to applying external forces in MD simulations, Jon Davis for his insight into previous experimental procedures related to the work, as well as members of the Lindert Lab for their discussions and suggestions. Additionally, we would like to thank the Ohio Supercomputer Center51 for valuable computational resources. This work was supported by the NIH (R01 HL137015 to S.L.).
Footnotes
Supporting Information
Contains methods for optimization of TMD simulation parameters, values for collective variables used for each window in US, interhelical angle analysis during TMD simulations, comparison of interhelical angle vs interhelical distance, coverage of collective variables in US simulations, free energy convergence of US simulations, and free energy analysis of cTnISP approaching a closed cTnCHP. This material is available free of charge via the Internet at https://urldefense.com/v3/__http://pubs.acs.org__;!!KGKeukY!3OgmlAsioVyYM4kbaaBu-WojFZYHZ5IlL7EbLxjj59XEyLuqKG3-zzBo7WTmy1-aaoZ3O5PB8_urAJKXpEMDnXjqOERS$
Data and Software Availability
The wildtype cTn protein structures (6KN7, 6KN8) were available in the Protein Data Bank (PDB) at https://www.rcsb.org/. All mutations were created using the wildtype protein structure as the base model within the PyMOL software using the protein mutagenesis tool. Phosphorylation was created using the wildtype protein structure as the base model within the PyMOL software using the PyTMs Plug-in. All TMD and umbrella sampling simulations were performed within the NAMD Version 2.13 framework. Weighted Histogram Analysis Method (WHAM) was performed using WHAM Version 2.0.11 available at http://membrane.urmc.rochester.edu/?page_id=126.
References
- (1).Marston S; Zamora JE Troponin structure and function: a view of recent progress. Journal of muscle research and cell motility 2019, 1–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (2).Lu QW; Wu XY; Morimoto S Inherited cardiomyopathies caused by troponin mutations. J Geriatr Cardiol 2013, 10 (1), 91–101. DOI: 10.3969/j.issn.1671-5411.2013.01.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (3).Ciarambino T; Menna G; Sansone G; Giordano M Cardiomyopathies: An Overview. Int J Mol Sci 2021, 22 (14). DOI: 10.3390/ijms22147722. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (4).Takeda S; Yamashita A; Maeda K; Maéda Y Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form. Nature 2003, 424 (6944), 35–41. DOI: 10.1038/nature01780. [DOI] [PubMed] [Google Scholar]
- (5).Yamada Y; Namba K; Fujii T Cardiac muscle thin filament structures reveal calcium regulatory mechanism. Nature Communications 2020, 11 (1), 1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (6).Bowman JD; Lindert S Computational Studies of Cardiac and Skeletal Troponin. Front Mol Biosci 2019, 6, 68. DOI: 10.3389/fmolb.2019.00068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (7).Lindert S; Kekenes-Huskey PM; Huber G; Pierce L; McCammon JA Dynamics and calcium association to the N-terminal regulatory domain of human cardiac troponin C: a multiscale computational study. J Phys Chem B 2012, 116 (29), 8449–8459. DOI: 10.1021/jp212173f. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (8).Rayani K; Seffernick J; Li AY; Davis JP; Spuches AM; Van Petegem F; Solaro RJ; Lindert S; Tibbits GF Binding of calcium and magnesium to human cardiac troponin C. J Biol Chem 2021, 296, 100350. DOI: 10.1016/j.jbc.2021.100350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (9).Hantz ER; Lindert S Adaptative Steered Molecular Dynamics Study of Mutagenesis Effects on Calcium Affinity in the Regulatory Domain of Cardiac Troponin C. J Chem Inf Model 2021, 61 (6), 3052–3057. DOI: 10.1021/acs.jcim.1c00419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (10).Rayani K; Hantz ER; Haji-Ghassemi O; Li AY; Spuches AM; Van Petegem F; Solaro RJ; Lindert S; Tibbits GF The effect of Mg(2+) on Ca(2+) binding to cardiac troponin C in hypertrophic cardiomyopathy associated TNNC1 variants. FEBS J 2022. DOI: 10.1111/febs.16578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (11).Votapka LW; Amaro RE Multiscale Estimation of Binding Kinetics Using Brownian Dynamics, Molecular Dynamics and Milestoning. PLoS Comput Biol 2015, 11 (10), e1004381. DOI: 10.1371/journal.pcbi.1004381. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (12).Kekenes-Huskey PM; Lindert S; McCammon JA Molecular basis of calcium-sensitizing and desensitizing mutations of the human cardiac troponin C regulatory domain: a multi-scale simulation study. PLoS Comput Biol 2012, 8 (11), e1002777. DOI: 10.1371/journal.pcbi.1002777. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (13).Dewan S; McCabe KJ; Regnier M; McCulloch AD; Lindert S Molecular Effects of cTnC DCM Mutations on Calcium Sensitivity and Myofilament Activation-An Integrated Multiscale Modeling Study. J Phys Chem B 2016, 120 (33), 8264–8275. DOI: 10.1021/acs.jpcb.6b01950. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (14).Stevens CM; Rayani K; Singh G; Lotfalisalmasi B; Tieleman DP; Tibbits GF Changes in the dynamics of the cardiac troponin C molecule explain the effects of Ca. J Biol Chem 2017, 292 (28), 11915–11926. DOI: 10.1074/jbc.M116.770776. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (15).Lindert S; Kekenes-Huskey PM; McCammon JA Long-timescale molecular dynamics simulations elucidate the dynamics and kinetics of exposure of the hydrophobic patch in troponin C. Biophys J 2012, 103 (8), 1784–1789. DOI: 10.1016/j.bpj.2012.08.058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (16).Bowman JD; Lindert S Molecular Dynamics and Umbrella Sampling Simulations Elucidate Differences in Troponin C Isoform and Mutant Hydrophobic Patch Exposure. J Phys Chem B 2018, 122 (32), 7874–7883. DOI: 10.1021/acs.jpcb.8b05435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (17).Bowman JD; Coldren WH; Lindert S Mechanism of Cardiac Troponin C Calcium Sensitivity Modulation by Small Molecules Illuminated by Umbrella Sampling Simulations. J Chem Inf Model 2019, 59 (6), 2964–2972. DOI: 10.1021/acs.jcim.9b00256. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (18).Zamora JE; Papadaki M; Messer AE; Marston SB; Gould IR Troponin structure: its modulation by Ca(2+) and phosphorylation studied by molecular dynamics simulations. Phys Chem Chem Phys 2016, 18 (30), 20691–20707. DOI: 10.1039/c6cp02610a. [DOI] [PubMed] [Google Scholar]
- (19).Cool AM; Lindert S Computational Methods Elucidate Consequences of Mutations and Post-translational Modifications on Troponin I Effective Concentration to Troponin C. J Phys Chem B 2021, 125 (27), 7388–7396. DOI: 10.1021/acs.jpcb.1c03844. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (20).Rao V; Cheng Y; Lindert S; Wang D; Oxenford L; McCulloch AD; McCammon JA; Regnier M PKA phosphorylation of cardiac troponin I modulates activation and relaxation kinetics of ventricular myofibrils. Biophys J 2014, 107 (5), 1196–1204. DOI: 10.1016/j.bpj.2014.07.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (21).Cheng Y; Lindert S; Kekenes-Huskey P; Rao VS; Solaro RJ; Rosevear PR; Amaro R; McCulloch AD; McCammon JA; Regnier M Computational studies of the effect of the S23D/S24D troponin I mutation on cardiac troponin structural dynamics. Biophys J 2014, 107 (7), 1675–1685. DOI: 10.1016/j.bpj.2014.08.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (22).Lindert S; Cheng Y; Kekenes-Huskey P; Regnier M; McCammon JA Effects of HCM cTnI mutation R145G on troponin structure and modulation by PKA phosphorylation elucidated by molecular dynamics simulations. Biophys J 2015, 108 (2), 395–407. DOI: 10.1016/j.bpj.2014.11.3461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (23).Cheng Y; Rao V; Tu AY; Lindert S; Wang D; Oxenford L; McCulloch AD; McCammon JA; Regnier M Troponin I Mutations R146G and R21C Alter Cardiac Troponin Function, Contractile Properties, and Modulation by Protein Kinase A (PKA)-mediated Phosphorylation. J Biol Chem 2015, 290 (46), 27749–27766. DOI: 10.1074/jbc.M115.683045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (24).Cheng Y; Lindert S; Oxenford L; Tu AY; McCulloch AD; Regnier M Effects of Cardiac Troponin I Mutation P83S on Contractile Properties and the Modulation by PKA-Mediated Phosphorylation. J Phys Chem B 2016, 120 (33), 8238–8253. DOI: 10.1021/acs.jpcb.6b01859. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (25).Lindert S; Li MX; Sykes BD; McCammon JA Computer-aided drug discovery approach finds calcium sensitizer of cardiac troponin. Chem Biol Drug Des 2015, 85 (2), 99–106. DOI: 10.1111/cbdd.12381. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (26).Cai F; Li MX; Pineda-Sanabria SE; Gelozia S; Lindert S; West F; Sykes BD; Hwang PM Structures reveal details of small molecule binding to cardiac troponin. J Mol Cell Cardiol 2016, 101, 134–144. DOI: 10.1016/j.yjmcc.2016.10.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (27).Aprahamian ML; Tikunova SB; Price MV; Cuesta AF; Davis JP; Lindert S Successful Identification of Cardiac Troponin Calcium Sensitizers Using a Combination of Virtual Screening and ROC Analysis of Known Troponin C Binders. J Chem Inf Model 2017, 57 (12), 3056–3069. DOI: 10.1021/acs.jcim.7b00536. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (28).Coldren WH; Tikunova SB; Davis JP; Lindert S Discovery of Novel Small-Molecule Calcium Sensitizers for Cardiac Troponin C: A Combined Virtual and Experimental Screening Approach. J Chem Inf Model 2020, 60 (7), 3648–3661. DOI: 10.1021/acs.jcim.0c00452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (29).Varughese JF; Baxley T; Chalovich JM; Li Y A computational and experimental approach to investigate bepridil binding with cardiac troponin. J Phys Chem B 2011, 115 (10), 2392–2400. DOI: 10.1021/jp1094504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (30).Li MX; Saude EJ; Wang X; Pearlstone JR; Smillie LB; Sykes BD Kinetic studies of calcium and cardiac troponin I peptide binding to human cardiac troponin C using NMR spectroscopy. Eur Biophys J 2002, 31 (4), 245–256. DOI: 10.1007/s00249-002-0227-1. [DOI] [PubMed] [Google Scholar]
- (31).Tikunova SB; Liu B; Swindle N; Little SC; Gomes AV; Swartz DR; Davis JP Effect of calcium-sensitizing mutations on calcium binding and exchange with troponin C in increasingly complex biochemical systems. Biochemistry 2010, 49 (9), 1975–1984. DOI: 10.1021/bi901867s. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (32).Cordina NM; Liew CK; Potluri PR; Curmi PM; Fajer PG; Logan TM; Mackay JP; Brown LJ Ca2+-induced PRE-NMR changes in the troponin complex reveal the possessive nature of the cardiac isoform for its regulatory switch. PLoS One 2014, 9 (11), e112976. DOI: 10.1371/journal.pone.0112976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (33).Schlitter J; Engels M; Krüger P Targeted molecular dynamics: a new approach for searching pathways of conformational transitions. J Mol Graph 1994, 12 (2), 84–89. DOI: 10.1016/0263-7855(94)80072-3. [DOI] [PubMed] [Google Scholar]
- (34).Ermakova E; Kurbanov R Molecular insight into conformational transformation of human glucokinase: conventional and targeted molecular dynamics. J Biomol Struct Dyn 2020, 38 (10), 3035–3045. DOI: 10.1080/07391102.2019.1652689. [DOI] [PubMed] [Google Scholar]
- (35).Wolf S; Amaral M; Lowinski M; Vallée F; Musil D; Güldenhaupt J; Dreyer MK; Bomke J; Frech M; Schlitter J; Gerwert K Estimation of Protein-Ligand Unbinding Kinetics Using Non-Equilibrium Targeted Molecular Dynamics Simulations. J Chem Inf Model 2019, 59 (12), 5135–5147. DOI: 10.1021/acs.jcim.9b00592. [DOI] [PubMed] [Google Scholar]
- (36).Trott O; Olson AJ AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of computational chemistry 2010, 31 (2), 455–461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (37).Phillips JC; Braun R; Wang W; Gumbart J; Tajkhorshid E; Villa E; Chipot C; Skeel RD; Kalé L; Schulten K Scalable molecular dynamics with NAMD. J Comput Chem 2005, 26 (16), 1781–1802. DOI: 10.1002/jcc.20289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (38).Huang J; MacKerell AD CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. J Comput Chem 2013, 34 (25), 2135–2145. DOI: 10.1002/jcc.23354. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (39).Tan Q; Ding Y; Qiu Z; Huang J Binding Energy and Free Energy of Calcium Ion to Calmodulin EF-Hands with the Drude Polarizable Force Field. ACS Physical Chemistry Au 2021, 2 (2), 143–155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (40).Wang D; Robertson IM; Li MX; McCully ME; Crane ML; Luo Z; Tu AY; Daggett V; Sykes BD; Regnier M Structural and functional consequences of the cardiac troponin C L48Q Ca(2+)-sensitizing mutation. Biochemistry 2012, 51 (22), 4473–4487. DOI: 10.1021/bi3003007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (41).Shettigar V; Zhang B; Little SC; Salhi HE; Hansen BJ; Li N; Zhang J; Roof SR; Ho HT; Brunello L; Lerch JK; Weisleder N; Fedorov VV; Accornero F; Rafael-Fortney JA; Gyorke S; Janssen PM; Biesiadecki BJ; Ziolo MT; Davis JP Rationally engineered Troponin C modulates in vivo cardiac function and performance in health and disease. Nat Commun 2016, 7, 10794. DOI: 10.1038/ncomms10794. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (42).Wang H; Grant JE; Doede CM; Sadayappan S; Robbins J; Walker JW PKC-betaII sensitizes cardiac myofilaments to Ca2+ by phosphorylating troponin I on threonine-144. J Mol Cell Cardiol 2006, 41 (5), 823–833. DOI: 10.1016/j.yjmcc.2006.08.016. [DOI] [PubMed] [Google Scholar]
- (43).The PyMOL Molecular Graphics System, Version 2.0 Schrödinger, LLC. [Google Scholar]
- (44).Warnecke A; Sandalova T; Achour A; Harris RA PyTMs: a useful PyMOL plugin for modeling common post-translational modifications. BMC Bioinformatics 2014, 15, 370. DOI: 10.1186/s12859-014-0370-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (45).Grossfield Alan, “WHAM: the weighted histogram analysis method”, version 2.0.11, http://membrane.urmc.rochester.edu/wordpress/?page_id=126.
- (46).Landstrom AP; Parvatiyar MS; Pinto JR; Marquardt ML; Bos JM; Tester DJ; Ommen SR; Potter JD; Ackerman MJ Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C. J Mol Cell Cardiol 2008, 45 (2), 281–288. DOI: 10.1016/j.yjmcc.2008.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (47).Yumoto F; Lu QW; Morimoto S; Tanaka H; Kono N; Nagata K; Ojima T; Takahashi-Yanaga F; Miwa Y; Sasaguri T; Nishita K; Tanokura M; Ohtsuki I Drastic Ca2+ sensitization of myofilament associated with a small structural change in troponin I in inherited restrictive cardiomyopathy. Biochem Biophys Res Commun 2005, 338 (3), 1519–1526. DOI: 10.1016/j.bbrc.2005.10.116. [DOI] [PubMed] [Google Scholar]
- (48).Willott RH; Gomes AV; Chang AN; Parvatiyar MS; Pinto JR; Potter JD Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function? J Mol Cell Cardiol 2010, 48 (5), 882–892. DOI: 10.1016/j.yjmcc.2009.10.031. [DOI] [PubMed] [Google Scholar]
- (49).Dong WJ; Jayasundar JJ; An J; Xing J; Cheung HC Effects of PKA phosphorylation of cardiac troponin I and strong crossbridge on conformational transitions of the N-domain of cardiac troponin C in regulated thin filaments. Biochemistry 2007, 46 (34), 9752–9761. DOI: 10.1021/bi700574n. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (50).Vymětal J; Jurásková V; Vondrášek J AMBER and CHARMM Force Fields Inconsistently Portray the Microscopic Details of Phosphorylation. J Chem Theory Comput 2019, 15 (1), 665–679. DOI: 10.1021/acs.jctc.8b00715. [DOI] [PubMed] [Google Scholar]
- (51).Center OS Ohio Supercomputer Center. 1987.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The wildtype cTn protein structures (6KN7, 6KN8) were available in the Protein Data Bank (PDB) at https://www.rcsb.org/. All mutations were created using the wildtype protein structure as the base model within the PyMOL software using the protein mutagenesis tool. Phosphorylation was created using the wildtype protein structure as the base model within the PyMOL software using the PyTMs Plug-in. All TMD and umbrella sampling simulations were performed within the NAMD Version 2.13 framework. Weighted Histogram Analysis Method (WHAM) was performed using WHAM Version 2.0.11 available at http://membrane.urmc.rochester.edu/?page_id=126.
